top of page
cooley.png

Athena on Boards | Cohort 6

March 2021 - July 2021 | POWERED BY COOLEY

VP, Scientific Strategy & Corporate Development

Zogenix

SVP, Accounting & Corporate Controller

Mitchell International

Chief Scientific Officer

Gossamer Bio

VP, Internal Audit & ERM

Illumina

Sr. Director, Alliance Management & Program Lead

Halozyme

Chief Commercial & Strategy Officer

Woebot Health

Sr. Director Product Management, Applications, & Services

Thermo Fisher Scientific

VP, Global Finance

NuVasive

CEO

Key Tech

Consultant & Science Journalist

Chief Medical Officer

Neurocrine Biosciences

VP, Assay Development

Genmark Diagnostics

Sr. Manager, Global Market Development

Thermo Fisher Scientific

President

Portavoce PR

Founder & CEO

Reveal Biosciences

VP, Human Resources

Genmark Diagnostics

VP, Finance & Corporate Secretary

Ambrx Inc.

 

 

Contact Athena CEO, Holly Smithson to secure your spot on the waitlist

for the next cohort and design your board search through Athena’s On Board Series.

Athena on Boards | Mentors

Chief Operations Officer

Upfront Resolution

CEO

RippleNami Inc.

VP, Corporate Marketing & Communications

Seer

Athena on Boards Committee

CO-CHAIR

CEO

RippleNami Inc.

CO-CHAIR

Partner

Cooley

Head of IT Program Office

Jack In The Box

Chief Financial Officer

Correlation Ventures

Audit Partner

BDO

bottom of page